Echinacea Purpurea Extract

BotanicalimmuneModerate dose evidence

Also known as: Echinacea purpurea, purple coneflower, echinacea herb and root, Echinacea angustifolia

Add to a formula

An extract of the aerial parts and root of purple coneflower, the classic North American immune herb. Evidence is mixed: a 2007 meta-analysis reported fewer colds and shorter duration with echinacea, while a later Cochrane review found only weak and inconsistent benefit across many preparations. Products differ widely in species, plant part, and extraction, which explains much of the variation. It remains a mainstream immune ingredient and is often blended with elderberry, zinc, and vitamin C.

Research summary

Alkylamides and polysaccharides are proposed to modulate macrophage activity and cytokine signaling; alkylamides also interact with cannabinoid receptors.

Dosage

Daily amounts, of extract.

Lowest studiedTypical rangeHighest studiedUpper limit
300–1,500 mg

300 to 1,500 mg per day of extract, usually split into three doses and used for short periods at symptom onset rather than continuously. Standardization to 4% phenolics or a specified alkylamide content improves consistency.

Standardization: 4% phenolic compounds (echinacoside/cichoric acid), preparation dependent

Source material: aerial parts and root extract

Format suitability

  • Capsule
  • Powder
  • Tablet
  • Softgel
  • Gummy
  • Liquid

Tingling, slightly bitter taste from alkylamides; workable in liquids and gummies at moderate doses.

Formulation notes

Ragweed-family plant; note for allergy-sensitive labeling. Typically paired with elderberry, zinc, and vitamin C.

Sources

  1. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. (Shah 2007)PubMed
  2. Echinacea for preventing and treating the common cold. (Karsch-Völk 2014)PubMed
  3. Echinacea — ExamineExamine

Related ingredients